Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Maze Therapeutics Inc.
Swot
Maze Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Maze Therapeutics Inc. has 10 Strengths, 6 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(6)
Opportunity
(3)
Threats
(2)
Others
(0)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Stock gained more than 20% in one month
Top Gainers
RSI indicating price strength
Highest Recovery from 52 Week Low
PE higher than Industry PE
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low durability companies
Declining profits every quarter for the past 3 quarters
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Stocks rising sharply on very low month volumes
Mutual Funds Decreased Shareholding in Past Month
